From Insight to Impact: Certainty EMEA 2025
See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…
CertaraNovember 17, 2025
Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals
Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.
CertaraNovember 14, 2025
The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]
Explore how Certara’s CoAuthor™ streamlines medical writing using generative AI, reducing repetitive tasks and improving…
CertaraNovember 14, 2025
Using M&S to Evaluate Oncology Drug Dosing
Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…
CertaraNovember 14, 2025
ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™
At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…
CertaraNovember 13, 2025
Modern SDTM Starts Here: Metadata Management with P21 Enterprise Plus
Discover how P21 Enterprise Plus modernizes SDTM metadata management for efficiency, consistency, and compliance across…
CertaraNovember 13, 2025
Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software
Certara and ANVISA have joined forces to enable eCTD 4.0 submissions in Brazil using GlobalSubmit™…
CertaraNovember 13, 2025
Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®
Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…
CertaraNovember 13, 2025
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema
Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…
CertaraNovember 12, 2025
Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs
Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…
CertaraNovember 12, 2025
